Urinary proteomics for the study of genetic kidney diseases

References

• Reeders ST, Breuning MH, Davies KE, et al. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature. 1985;317:542–544.
   PubMed Web of Science ®Google Scholar
• Barker DF, Hostikka SL, Zhou J, et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990;248:1224–1227.
   PubMed Web of Science ®Google Scholar
• Devuyst O, Knoers NV, Remuzzi G, et al. Board of the working group for inherited kidney diseases of the european renal association and european dialysis and transplant association. rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet. 2014 May 24;383:1844–1859.
   PubMed Web of Science ®Google Scholar
• Hessheimer JA, Vidal O, Valentini M, et al. Pheochromocytoma as a rare cause of arterial hypertension in a patient with autosomal dominant polycystic kidney disease: a diagnostic and therapeutic dilemma. Int J Surg Case Rep. 2015;14:85–88.
   PubMed Web of Science ®Google Scholar
• Hildebrandt F. Genetic kidney diseases. Lancet. 2010;375:1287–1295.
   PubMed Web of Science ®Google Scholar
• Shao L, Ren H, Wang W, et al. Novel SLC12A3 mutations in Chinese patients with Gitelman’s syndrome. Nephron Physiol. 2008;108:29–36.
   Google Scholar
• Riveira-Munoz E, Chang Q, Bindels RJ. Devuyst O Gitelman’s syndrome: towards genotype-phenotype correlations? Pediatr Nephrol. 2007;22:326–332.
   PubMed Web of Science ®Google Scholar
• Nozu K, Iijima K, Nozu Y, et al. A deep intronic mutation in the SLC12A3 gene leads to Gitelman syndrome. Pediatr Res. 2009;66:590–593.
   PubMed Web of Science ®Google Scholar
• Bruschi M, Ravera S, Santucci L, et al. The human urinary exosome as a potential metabolic effector cargo. Expert Rev Proteomics. 2015;12:425–432.
   PubMed Web of Science ®Google Scholar
• Vaidyanathan K. Urinary proteomics and metabolomics in the diagnosis of pediatric disorders. Proteomics Clin Appl. 2015;9:482–489.
   PubMed Web of Science ®Google Scholar
• Zheng J, Liu L, Wang J, et al. Urinary proteomic and non-prefractionation quantitative phosphoproteomic analysis during pregnancy and non-pregnancy. BMC Genomics. 2013;14:1–10.
   PubMed Web of Science ®Google Scholar
• Muntel J1, Xuan Y2, Berger ST, et al. Advancing urinary protein biomarker discovery by data-independent acquisition on a quadrupole-Orbitrap mass spectrometer. Proteome Res. 2015;14:4752–4762.
   PubMed Web of Science ®Google Scholar
• Decramer S. Gonzalez de Peredo A, Breuil B et al. Urine in Clinical Proteomics. Mol Cell Proteomics. 2008;7:1850–1862.
   PubMed Web of Science ®Google Scholar
• Pontillo C, Filip S, Borràs DM, et al. CE-MS-based proteomics in biomarker discovery and clinical application. Proteomics Clin Appl. 2015;9:322–334.
   PubMed Web of Science ®Google Scholar
• Good DM, Zürbig P, Argilés A, et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics. 2010;9:2424–2437.
   PubMed Web of Science ®Google Scholar
• Chahrour O, Cobice D, Malone J. Stable isotope labelling methods in mass spectrometry-based quantitative proteomics. J Pharm Biomed Anal. 2015;113:2–20.
   PubMed Web of Science ®Google Scholar
• Megger DA, Bracht T, Meyer HE, et al. Label-free quantification in clinical proteomics. Biochim Biophys Acta. 2013;1834:1581–1590.
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289.
   PubMed Web of Science ®Google Scholar
• Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci.USA. 2004;101:13368–13373.
   PubMed Web of Science ®Google Scholar
• Hoorn EJ, Pisitkun T, Zietse R, et al. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton). 2005;10:283–290.
   PubMed Web of Science ®Google Scholar
• Moon PG, You S, Lee JE, et al. Urinary exosomes and proteomics. Mass Spectrom Rev. 2011;30:1185–1202.
   PubMed Web of Science ®Google Scholar
• Gámez-Valero A, Lozano-Ramos SI, Bancu I, et al. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol. 2015;6:6.
   PubMed Web of Science ®Google Scholar
• Erdbrügger U, Le TH. Extracellular vesicles in renal diseases: more than novel biomarkers? J Am Soc Nephrol. 2015. published online 6 August 2015. doi:10.1681/ASN.2015010074.
   PubMed Web of Science ®Google Scholar
• Musante L, Tataruch DE, Holthofer H. Use and isolation of urinary exosomes as biomarkers for diabetic nephropathy. Front Endocrinol (Lausanne). 2014;5:149.
   PubMed Web of Science ®Google Scholar
• Raimondo F, Corbetta S, Chinello C, et al. The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques. Expert Rev Proteomics. 2014;11:503–514.
   PubMed Web of Science ®Google Scholar
• Salih M, Zietse R, Hoorn EJ. Urinary extracellular vesicles and the kidney: biomarkers and beyond. Am J Physiol Renal Physiol. 2014;306:F1251F1259.
   Web of Science ®Google Scholar
• Wood SL, Knowles MA, Thompson D, et al. Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers. Nat Rev Urol. 2013;10:206–218.
   PubMed Web of Science ®Google Scholar
• Felder RA, White MJ, Williams SM, et al. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens. 2013;22:65–76.
   PubMed Web of Science ®Google Scholar
• Dear JW, Street JM, Bailey MA. Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics. 2013;13:1572–1580.
   PubMed Web of Science ®Google Scholar
• Santucci L, Candiano G, Bruschi M, et al. Urinary proteome in a snapshot: normal urine and glomerulonephritis. J Nephrol. 2013;26:610–616.
   PubMed Web of Science ®Google Scholar
• Ranghino A, Dimuccio V, Papadimitriou E, et al. Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration. Clin Kidney J. 2015;8:23–30.
   PubMed Web of Science ®Google Scholar
• Hogan MC, Bakeberg JL, Gainullin VG, et al. Identification of biomarkers for PKD1 using urinary exosomes. J Am Soc Nephrol. 2015;26:1661–1670.
   PubMed Web of Science ®Google Scholar
• Corbetta S, Raimondo F, Tedeschi S, et al. Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes. Nephrol Dial Transplant. 2015;30:621–630.
   PubMed Web of Science ®Google Scholar
• Chacon-Heszele MF, Choi SY, Zuo X, et al. The exocyst and regulatory GTPases in urinary exosomes. Physiol Rep. 2014;2:e12116.
   PubMedGoogle Scholar
• Hiemstra TF, Charles PD, Gracia T, et al. Human urinary exosomes as innate immune effectors. J Am Soc Nephrol. 2014;25:2017–2027.
   PubMed Web of Science ®Google Scholar
• Raimondo F, Morosi L, Corbetta S, et al. Differential protein profiling of renal cell carcinoma urinary exosomes. Mol Biosyst. 2013;9:1220–1233.
   PubMed Web of Science ®Google Scholar
• Mischak H. Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures! Nephrol Dial Transplant. 2015;30:532–537.
   PubMed Web of Science ®Google Scholar
• Wu J, Gao Y. Physiological conditions can be reflected in human urine proteome and metabolome. Expert Rev Proteomics. 2015;15:1–14.
   Google Scholar
• Albalat A, Mischak H, Mullen W. Clinical application of urinary proteomics/peptidomics. Expert Rev Proteomics. 2011;8:615–629.
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V. Practical points in urinary proteomics. J Proteome Res. 2007;6:3881–3890.
   PubMed Web of Science ®Google Scholar
• Zhou H, Yuen PS, Pisitkun T, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int. 2006;69:1471–1476.
   PubMed Web of Science ®Google Scholar
• Cheruvanky A, Zhou H, Pisitkun T, et al. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol. 2007;292:F1657F1661.
   Web of Science ®Google Scholar
• Jacquillet G, Hoorn EJ, Vilasi A, et al. Urinary vesicles: in splendid isolation. Nephrol Dial Transplant. 2013;28:1332–1335.
   PubMed Web of Science ®Google Scholar
• Oosthuyzen W, Sime NE, Ivy JR, et al. Quantification of human urinary exosomes by nanoparticle tracking analysis. J Physiol. 2013;591:5833–5842.
   PubMed Web of Science ®Google Scholar
• Boukouris S, Mathivanan S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin Appl. 2015;9:358–367.
   PubMed Web of Science ®Google Scholar
• Alvarez ML, Khosroheidari M, Kanchi Ravi R, et al. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82:1024–1032.
   PubMed Web of Science ®Google Scholar
• Lhotta K. Uromodulin and chronic kidney disease. Kidney Blood Press Res. 2010;33:393–398.
   PubMed Web of Science ®Google Scholar
• Mischak H, Delles C, Klein J, et al. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application. Adv Chronic Kidney Dis. 2010;17:493–506.
   PubMed Web of Science ®Google Scholar
• Raimondo F, Corbetta S, Morosi L, et al. Urinary exosomes and diabetic nephropathy: a proteomic approach. Mol Biosyst. 2013;9:1139–1146.
   PubMed Web of Science ®Google Scholar
• Sancho-Martínez SM, Prieto-García L, Blanco-Gozalo V, et al. Urinary proteomics in renal pathophysiology: impact of proteinuria. Proteomics Clin Appl. 2015;9:636–640.
   PubMed Web of Science ®Google Scholar
• Nolen BM, Orlichenko LS, Marrangoni A, et al. An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors. PLoS One. 2013;8:e63368.
   PubMed Web of Science ®Google Scholar
• Jantos-Siwy J, Schiffer E, Brand K, et al. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J Prot Res. 2009;8:268–281.
   PubMed Web of Science ®Google Scholar
• Scolari F, Izzi C, Ghiggeri GM. Uromodulin: from monogenic to multifactorial diseases. Nephrol Dial Transplant. 2015;30:1250–1256.
   PubMed Web of Science ®Google Scholar
• Street JM, Birkhoff W, Menzies RI, et al. Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J Physiol. 2011;589:6119–6127.
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Balaj L, Alian S, et al. Alternative methods for characterization of extracellular vesicles. Front Physiol. 2012;3:354.
   PubMed Web of Science ®Google Scholar
• Sitar S, Kejžar A, Pahovnik D, et al. Size characterization and quantification of exosomes by asymmetrical-flow field-flow fractionation. Anal Chem. 2015;87:9225–9233.
   PubMed Web of Science ®Google Scholar
• Stoner SA, Duggan E, Condello D, et al. High sensitivity flow cytometry of membrane vesicles. Cytometry A. 2015. published online 20 October 2015. doi:10.1002/cyto.a.22787.
   PubMedGoogle Scholar
• Maas SL, de Vrij J, van der Vlist EJ, et al. Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics. J Control Release. 2015;200:87–96.
   PubMed Web of Science ®Google Scholar
• Harris PC, Torres VE. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest. 2014;124:2315–2324.
   PubMed Web of Science ®Google Scholar
• Hartung EA, Guay-Woodford LM. Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects. Pediatrics. 2014;134:e833e845.
   Web of Science ®Google Scholar
• Hogan MC, Manganelli L, Woollard JR, et al. Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol. 2009;20:278–288.
   PubMed Web of Science ®Google Scholar
• Pampliega O, Orhon I, Patel B, et al. Functional interaction between autophagy and ciliogenesis. Nature. 2013;502:194–200.
   PubMed Web of Science ®Google Scholar
• Wood CR, Huang K, Diener DR, et al. The cilium secretes bioactive ectosomes. Curr Biol. 2013;23:906–911.
   PubMed Web of Science ®Google Scholar
• Gerlach JQ, Krüger A, Gallogly S, et al. Surface glycosylation profiles of urine extracellular vesicles. PLoS One. 2013;8:e74801.
   PubMed Web of Science ®Google Scholar
• Pocsfalvi G, Raj DA, Fiume I, et al. Urinary extracellular vesicles as reservoirs of altered proteins during the pathogenesis of polycystic kidney disease. Proteomics Clin Appl. 2015;9:552–567.
   PubMed Web of Science ®Google Scholar
• Kelly KJ, Zhang J, Han L, et al. Improved structure and function in autosomal recessive polycystic rat kidneys with renal tubular cell therapy. PLoS ONE. 2015;10:e0131677.
   Google Scholar
• Kistler AD, Mischak H, Poster D, et al. Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int. 2009;76:89–96.
   Google Scholar
• Zürbig P, Jerums G, Hovind P, et al. Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes. 2012;61:3304–3313.
   PubMed Web of Science ®Google Scholar
• Chinello C, Cazzaniga M, De Sio G, et al. Urinary signatures of renal cell carcinoma investigated by peptidomic approaches. Plos One. 2014;9:e106684.
   PubMed Web of Science ®Google Scholar
• Chinello C, Cazzaniga M, De Sio G, et al. Tumor size, stage and grade alterations of urinary peptidome in RCC. J Transl Med. 2015;13:332.
   PubMed Web of Science ®Google Scholar
• Kistler AD, Serra AL, Siwy J, et al. Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS One. 2013;8:e53016.
   PubMed Web of Science ®Google Scholar
• Savige J. Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment. J Physiol. 2014;592:4013–4023.
   PubMed Web of Science ®Google Scholar
• Pohl M, Danz K, Gross O, et al. Diagnosis of Alport syndrome–search for proteomic biomarkers in body fluids. Pediatr Nephrol. 2013;28:2117–2123.
   PubMed Web of Science ®Google Scholar
• Baum A, Pohl M, Kreusch S, et al. Searching biomarker candidates in serum using multidimensional native chromatography. II Method evaluation with Alport syndrome and severe inflammation. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;876:31–40.
   PubMed Web of Science ®Google Scholar
• Waldek S, Feriozzi S. Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy? BMC Nephrol. 2014;15:72.
   PubMed Web of Science ®Google Scholar
• Vojtova L, Zima T, Tesar V, et al. Study of urinary proteomes in Anderson-Fabry disease. Ren Fail. 2010;32:1202–1209.
   PubMed Web of Science ®Google Scholar
• Kistler AD, Siwy J, Breunig F, et al. A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy. PLoS One. 2011;6:e20534.
   PubMed Web of Science ®Google Scholar
• Matafora V, Cuccurullo M, Beneduci A, et al. Early markers of Fabry disease revealed by proteomics. Mol Biosyst. 2015;11:1543–1551.
   PubMed Web of Science ®Google Scholar
• Schulze H, Sandhoff K. Sphingolipids and lysosomal pathologies. Biochim Biophys Acta. 2014;1841:799–810.
   PubMed Web of Science ®Google Scholar
• Manwaring V, Heywood WE, Clayton R, et al. The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: evidence of presymptomatic kidney disease in pediatric Fabry and type-I diabetic patients. J Proteome Res. 2013;12:2013–2021.
   PubMed Web of Science ®Google Scholar
• Klootwijk ED, Reichold M, Unwin RJ, et al. Renal Fanconi syndrome: taking a proximal look at the nephron. Nephrol Dial Transplant. 2015;30:1456–1460.
   PubMed Web of Science ®Google Scholar
• Cutillas PR, Norden AG, Cramer R, et al. Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome. Clin Sci (Lond). 2003;104:483–490.
   PubMed Web of Science ®Google Scholar
• Cutillas PR, Chalkley RJ, Hansen KC, et al. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am J Physiol Renal Physiol. 2004;287:F353F364.
   Web of Science ®Google Scholar
• Norden AG, Sharratt P, Cutillas PR, et al. Quantitative amino acid and proteomic analysis: very low excretion of polypeptides >750 Da in normal urine. Kidney Int. 2004;66:1994–2003.
   PubMed Web of Science ®Google Scholar
• Vilasi A, Cutillas PR, Maher AD, et al. Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. Am J Physiol Renal Physiol. 2007;293:F456F467.
   Web of Science ®Google Scholar
• Christensen EI, Devuyst O, Dom G, et al. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci USA. 2003;100:8472–8477.
   PubMed Web of Science ®Google Scholar
• Santucci L, Candiano G, Anglani F, et al. Urine proteome analysis in Dent’s disease shows high selective changes potentially involved in chronic renal damage. J Proteomics. 2015. published online 11 September 2015. doi:10.1016/j.jprot.2015.08.024.
   Web of Science ®Google Scholar
• Drube J, Schiffer E, Mischak H, et al. Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol Dial Transplant. 2009;24:2161–2169.
   PubMed Web of Science ®Google Scholar
• Saravakos P, Kokkinou V, Giannatos E. Cystinuria: current diagnosis and management. Urology. 2014;83:693–699.
   PubMed Web of Science ®Google Scholar
• Kovacevic L, Lu H, Goldfarb DS, et al. Urine proteomic analysis in cystinuric children with renal stones. J Pediatr Urol. 2015;11:217.e1-e 6.
   Web of Science ®Google Scholar
• Bourderioux M, Nguyen-Khoa T, Chhuon C, et al. A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients. J Proteome Res. 2015;14:567–577.
   PubMed Web of Science ®Google Scholar
• Joo KW, Lee JW, Jang HR, et al. Reduced urinary excretion of thiazide-sensitive Na-Cl cotransporter in Gitelman syndrome: preliminary data. Am J Kidney Dis. 2007;50:765–773.
   PubMed Web of Science ®Google Scholar
• Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol. 2011;26:1789–1802.
   PubMed Web of Science ®Google Scholar
• Grimm PR, Lazo-Fernandez Y, Delpire E, et al. Integrated compensatory network is activated in the absence of NCC phosphorylation. J Clin Invest. 2015;125:2136–2150.
   PubMed Web of Science ®Google Scholar